HEPARIN RESISTANCE DURING CARDIOPULMONARY BYPASS - THE ROLE OF HEPARIN PRETREATMENT

被引：0
|
作者：
ESPOSITO, RA
CULLIFORD, AT
COLVIN, SB
THOMAS, SJ
LACKNER, H
SPENCER, FC
机构：
[1] NYU MED CTR,DEPT SURG,NEW YORK,NY 10016
[2] NYU MED CTR,DEPT MED,NEW YORK,NY 10016
[3] NYU MED CTR,DEPT ANESTHESIOL,NEW YORK,NY 10016
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 1983年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：346 / 353
页数：8
相关论文
共 50 条
  • [41] ACTIVATED CLOTTING TIME AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    SWAANENBURG, JCJM
    BRENKEN, U
    BAKKER, HAM
    CLINICAL CHEMISTRY, 1990, 36 (06) : 975 - 975
  • [42] HEPARIN BONDING OF BYPASS CIRCUITS REDUCES CYTOKINE RELEASE DURING CARDIOPULMONARY BYPASS
    STEINBERG, BM
    GROSSI, EA
    SCHWARTZ, DS
    MCLOUGHLIN, DE
    AGUINAGA, M
    BIZEKIS, C
    GREENWALD, J
    FLISSER, A
    SPENCER, FC
    GALLOWAY, AC
    COLVIN, SB
    ANNALS OF THORACIC SURGERY, 1995, 60 (03): : 525 - 529
  • [43] Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members
    Sniecinski, Roman M.
    Bennett-Guerrero, Elliott
    Shore-Lesserson, Linda
    ANESTHESIA AND ANALGESIA, 2019, 129 (02): : E41 - E44
  • [44] CAN HEPARIN BE REPLACED BY LMW HEPARIN IN CARDIOPULMONARY BYPASS-SURGERY
    WALENGA, JM
    KOZA, M
    PARK, S
    KHENKINA, Y
    GORT, E
    WOLF, H
    PIFARRE, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 935 - 935
  • [45] Use of plasma exchange and heparin during cardiopulmonary bypass for a patient with heparin induced thrombocytopenia: A case report
    Kajitani, M
    Aguinaga, M
    Johnson, CE
    Scott, MA
    Antakli, T
    JOURNAL OF CARDIAC SURGERY, 2001, 16 (04) : 313 - 318
  • [46] THE ROLE OF THE ACTIVATED CLOTTING TIME IN HEPARIN ADMINISTRATION AND NEUTRALIZATION FOR CARDIOPULMONARY BYPASS
    ESPOSITO, RA
    CULLIFORD, AT
    COLVIN, SB
    THOMAS, SJ
    LACKNER, H
    SPENCER, FC
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 85 (02): : 174 - 185
  • [47] Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass
    Delavenne, X.
    Ollier, E.
    Chollet, S.
    Sandri, F.
    Lanoiselee, J.
    Hodin, S.
    Montmartin, A.
    Fuzellier, J-F.
    Mismetti, P.
    Gergele, L.
    BRITISH JOURNAL OF ANAESTHESIA, 2017, 118 (05) : 705 - 712
  • [48] Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass
    Audrick Gibert
    Julien Lanoiselée
    Isabelle Gouin-Thibault
    Adeline Pontis
    Kasra Azarnoush
    Andranik Petrosyan
    Nathalie Grand
    Serge Molliex
    Jérome Morel
    Laurent Gergelé
    Sophie Hodin
    Valérie Bin
    Robin Chaux
    Xavier Delavenne
    Edouard Ollier
    Clinical Pharmacokinetics, 2024, 63 : 211 - 225
  • [49] USE OF LMW HEPARIN DURING CARDIOPULMONARY BYPASS-SURGERY IN PIGS
    MAMMEN, EF
    FUJII, Y
    WOJTUKIEWICZ, MZ
    DIMARTINO, L
    BROWNCASTILLO, J
    SPLITTGERBER, FH
    DAWE, EJ
    WILSON, RF
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 522 - 522
  • [50] CLEARANCE OF HEPARIN IS TEMPERATURE-DEPENDENT DURING HYPOTHERMIC CARDIOPULMONARY BYPASS
    SULLIVAN, DM
    COHEN, JA
    ALEXANDER, JA
    KITCHENS, CS
    CLINICAL RESEARCH, 1984, 32 (02): : A248 - A248
12345